Acipimox
Product Specifications
UNSPSC Description
Acipimox (K-9321), a nicotinic acid analogue, is an antilipolytic compound. Acipimox stimulates leptin releas, inhibits lipolysis and suppresses systemic levels of free fatty acids (FFAs) and improves insulin sensitivity[1][2][3].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/Acipimox.html
Purity
99.86
Solubility
DMSO : ≥ 100 mg/mL|H2O : 20 mg/mL (ultrasonic)
Smiles
O=C(C1=C[N+]([O-])=C(C)C=N1)O
Molecular Weight
154.125
References & Citations
[1]Vestergaard ET, et, al. Short-term acipimox treatment is associated with decreased cardiac parasympathetic modulation. Br J Clin Pharmacol. 2017 Dec;83(12):2671-2677.|[2]Wang-Fisher YL, et, al. Acipimox stimulates leptin production from isolated rat adipocytes. J Endocrinol. 2002 Aug;174(2):267-72.|[3]Ahrén B. Reducing plasma free fatty acids by acipimox improves glucose tolerance in high-fat fed mice. Acta Physiol Scand. 2001 Feb;171(2):161-7.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-B0283/Acipimox-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-B0283/Acipimox-SDS-MedChemExpress.pdf
Clinical Information
Launched
CAS Number
51037-30-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6327659-01 0.2 mL
OGN, CT (OGN, OIF, SLRR3A, Mimecan, Osteoglycin, Osteoinductive factor) (FITC)
Ask
View Details 
MBS6327659-02 5x 0.2 mL
OGN, CT (OGN, OIF, SLRR3A, Mimecan, Osteoglycin, Osteoinductive factor) (FITC)
Ask
View Details ![Mouse Monoclonal Collagen VII Antibody (LH7.2) [PerCP]](https://cdn.genprice.uk/genprice/genprice5.png)